BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18

• Press Releases

  CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

  December 3, 2025

   · 

  5 min read
• Press Releases

  PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)

  December 3, 2025

   · 

  6 min read
• Press Releases

  Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

  December 3, 2025

   · 

  3 min read
• Press Releases

  Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

  December 3, 2025

   · 

  4 min read
• Press Releases

  PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

  December 3, 2025

   · 

  5 min read
• Press Releases

  ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors

  December 3, 2025

   · 

  3 min read
• Press Releases

  AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

  December 3, 2025

   · 

  26 min read
• Press Releases

  Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging

  December 3, 2025

   · 

  7 min read
• Press Releases

  BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

  December 3, 2025

   · 

  2 min read
• Orbus Therapeutics Announces Publication of Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Improvements in Rare Brain Tumor in Journal of Clinical Oncology (JCO)

  December 3, 2025

   · 

  5 min read